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Abstract
Stents are commonly used in medical procedures to alleviate the symptoms of coronary heart disease, a prevalent
modern society disease. These structures are employed to maintain vessel patency and restore blood flow.
Traditionally stents are made of metals such as stainless steel or cobalt chromium; however, these scaffolds have
known disadvantages. An emergence of transient scaffolds is gaining popularity, with the structure engaged for a
required period whilst healing of the diseased arterial wall occurs. Polymers dominate a medical device sector, with
incorporation in sutures, scaffolds and screws. Thanks to their good mechanical and biological properties and their
ability to degrade naturally. Polylactic acid is an extremely versatile polymer, with its properties easily tailored to
applications. Its dominance in the stenting field increases continually, with the first polymer scaffold gaining FDA
approval in 2016. Still some challenges with PLLA bioresorbable materials remain, especially with regard to
understanding their mechanical response, assessment of its changes with degradation and comparison of their
performance with that of metallic drug-eluting stent. Currently, there is still a lack of works on evaluating both the
pre-degradation properties and degradation performance of these scaffolds. Additionally, there are no established
material models incorporating non-linear viscoelastic behaviour of PLLA and its evolution with in-service
degradation. Assessing these features through experimental analysis accompanied by analytical and numerical
studies will provide powerful tools for design and optimisation of these structures endorsing their broader use in
stenting. This overview assesses the recent studies investigating mechanical and computational performance of
poly(l-lactic) acid and its use in stenting applications.
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Introduction
Atherosclerosis, a type of coronary heart disease (CHD), is
a process, in which a build-up of fatty material (atheroma)
occurs inside arterial walls (Fig. 1). This leads to narrow-
ing of the artery, causing severe ailments (i.e., heart attack
or angina) and a high rate of fatality (NHS 2014). CHD is
a leading cause of mortality worldwide and contributes to
the death of more than one in seven men and almost one
in ten women in the United Kingdom, making it the UK’s
biggest killer (British Heart Foundation 2015).
Coronary artery bypass grafting (CABG) or percutan-
eous coronary intervention (PCI) are generally used to
treat patients with a coronary artery disease. CABG is a
procedure, where a healthy artery section is removed from
another site in the body and grafted in order to bypass the
site of occlusion, ultimately creating a new path for con-
tinuous blood flow (NIH 2012). In contrast, PCI is a non-
surgical procedure, with the occluded artery section wid-
ened through inflation of a balloon mounted onto a cath-
eter (Fig. 2). Balloon angioplasty, pioneered by Andres
Grüntzig in 1977, was the first procedure by which med-
ical professionals were able to intervene non-surgically in
order to establish coronary revascularization (Gruntzig
1978; Simard et al. 2014; Kočka et al. 2015). This method
was found to be effective in initiating patency to a nar-
rowed or blocked artery; however, severe life-threatening
risks were also associated with it as a result of a high
threat of restenosis (occurrence of vessel blockage trig-
gered by arterial remodelling and intima hyperplasia) due
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Fig. 1 Atherosclerosis sequence (Widmer et al. 2016)
Fig. 2 PCI procedure illustrating stent implant (Fortier et al. 2014)
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to coronary dissection and arterial recoil (Oberhauser et
al. 2009; Serruys et al. 2012; Bourantas et al. 2013; Simard
et al. 2014; Kočka et al. 2015).
The development of coronary stents began in the
1980s as a means to overcome the restenosis issues re-
lated to balloon angioplasty (Hoffmann and Mintz 2000;
Kočka et al. 2015). This scheme is based on the intro-
duction of scaffolding of the artery with balloon inflated
metallic stents averting early constrictive remodelling,
stabilizing vascular dissections and eliminating arteral
recoil. Bare metal stents (BMSs) were introduced to alle-
viate problems seen with balloon angioplasty, e.g. acute
vessel closure caused by dissection, elastic recoil, neoin-
timal proliferation and a late occurrence of constrictive
remodelling (Hara et al. 2006; O′ Brien et al. 2011; Iqbal
et al. 2014; Simard et al. 2014). Generally, the permanent
structures were able to maintain a widened lumen and
deemed an improvement on balloon angioplasty; how-
ever, the occurrences of in-stent restenosis increased
with time as a result of neointimal proliferation (Schatz
et al. 1991). Although incidences of restenosis declined
with BMS implants, vessel narrowing still occurred in
20–30% of stented lesions (Serruys et al. 1994). Bare
metal stents also pose a risk to surgical revasculariaza-
tion and impaired non-invasive imaging techniques,
such as multi-slice computed tomography, used to image
an implant in vivo (Agrawal et al. 1992; Serruys et al.
2009; Oberhauser et al. 2009; Nishio et al. 2012). Per-
manent metallic stents also have potential to jail side
branches, prevent expansive positive remodelling and
eliminate reactive vasomotion (Ormiston et al. 2008).
The risk of complication is even more critical due to fa-
tigue loading, experienced by a stented artery and
caused by a compliance disparity between the metal im-
plant and the arterial wall (Nishio et al. 2012). In order
to overcome these limitations, research was directed at
new types of stents.
In 2002, the third generation of stents (see Table 1), drug
eluting stent (DES), was introduced. These stents were
based on permanent scaffolds, i.e., a metallic backbone
with a polymeric drug-delivery coating (Kočka et al. 2015).
The main objective of DES was to reduce a vascular in-
flammatory response and cell proliferation in order to
eliminate an excessive hyperplastic healing response ob-
served in BMSs to diminish a chance of ISR occurance
(Abizaid and Costa Jr., 2010; Simard et al. 2014; Verheye
et al. 2014). Pharmacologic agents commonly used in
DESs are usually cytotoxic, antiproliferative and/or im-
munosuppressive to reduce a growth of smooth muscle
cells growth post coronary intervention (Simard et al.
2014). Studies showed that drug-eluting stents, in com-
parison to BMSs, minimize smooth-muscle proliferation
(neointimal hyperplasia), reduced restenosis and decreased
the rates of target lesion revascularization by 50–70% (Ser-
ruys et al. 2006; Kočka et al. 2015). Unfortunately, safety
problems arose with the use of first-generation DESs par-
ticularly, with respect to late stent thrombosis that delayed
healing (Gada et al. 2013). This is associated with antipro-
lifertive drugs used to coat the stent backbone, delaying
endothelialisation of the implanted stent (Iakovou et al.
2005). Additionally, polymers used to load drugs onto the
stent surface, could initiate an inflammatory response con-
tributing to a prothrombotic environment (Kristensen and
Grove 2007). To address these issues, second-generation
DESs were developed, with thinner struts, enhanced bio-
compatibility and biodegradable polymers for the stent
backbone. This greatly improved the safety profile of DESs
however, they were still permanent implants. A new gener-
ation of stents, bioresorbable scaffolds, are under research
and development, with a focus on full biodegradability.
Absorbable cardiovascular scaffolds deliver temporary
support to vasculature; they are implanted with the
intention of degradation and resorption by the body’s
metabolic pathways, the key notion being the transient re-
quirement for vessel scaffolding (Oberhauser et al. 2009).
Scaffolds play a role in vascular restoration therapy, in-
volving an endothelial function and vasomotion, where
endothelium dysfunction was shown to be reversible
(Celermajer 1997; Oberhauser et al. 2009). In comparison
to permanent stenting (BMSs & DESs), bioresorbable stents
enhance arterial recovery, allowing the vessel to react nor-
mally to pulsatile flow, positively remodel and respond in a
normal manner to biochemical factors released by the
endothelium (Ormiston et al. 2007). Functional endothelial
coverage can also contribute towards a diminished risk of
stent thrombosis and meet a requirement for long-term use
of antiplatelet therapy (Ormiston and Serruys 2009). Res-
toration of mechano-transduction, adaptive shear stress,
late luminal gain (as opposed to late luminal loss as seen
with permanent stents) and late expansive remodelling are
major enhancements achieved with BRSs (Serruys et al.
2012; Iqbal et al. 2014). The predominant aspect which dis-
tinguishes bioabsorbable stents from BMSs and DESs, is a
capacity to restore natural vascular response in the vessel.
Together with a significant reduction in restenosis and late
stent thrombosis as well as a potential for re-intervention
at the injury site, reduction in dual antiplatelet therapy pre-
scription and improved non-invasive imaging bioabsorbable
stents are an extraordinary device, which could change the
outcomes of PCI (Oberhauser et al. 2009). Bioresorbable
stents also have higher flexibility in comparison to metal
Table 1 Stent evolution
1st Generation (1977) •Balloon Angioplasty
2nd Generation (1980's) •Bare metal stents
3rd Generation (2002) •Drug-eluting stents (permanent)
4th Generation (2016) •Drug-eluting stents (bioresorbable)
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ones, enabling better tracking when implanting the device
into complex anatomies (Bourantas et al. 2013). A compari-
son of main types of stents is given in Table 2.
The intent of temporary scaffolding of the artery is to
provide initial mechanical support, but with elastic re-
coil, constrictive remodelling and endothelium dysfunc-
tion being of concern. Alleviation of these matters make
permanent stenting redundant after the vessel has fully
recovered (Oberhauser et al. 2009; Simard et al. 2014). It
is therefore crucial, in order to achieve successful revas-
cularization at the injury site, that there is a sufficient
level of luminal support for the required time frame
(Luo et al. 2014). This involves the adjustment of device
performance (i.e., duration of radial scaffolding and struc-
tural continuity), with the consideration of physiological
behaviours (e.g. lumen stabilization and cellular matrix de-
position). Bioabsorbable scaffolds are revolutionizing car-
diovascular interventions; however their use in clinical
procedures is still sparse due to the lack of experimental
and computational analysis of their efficiency and suitabil-
ity. This review assesses the current state of such studies
performed in the past 15 years to contribute to accelerated
introduction of implants into medical practice. It covers
mechanical testing of PLLA material and scaffolds and ad-
dresses factors, affecting behaviour of polymer. Computa-
tional studies of PLLA scaffolds introduced in more
recent years are also noted and discussed.
Review
Poly (L-lactic) acid used in bioresorbable stenting
Material
PLLA is the material currently used for bioresorbable stents
available on the market, due to its high biocompatibility,
reasonable rates of biodegradation and adaptable physical
and chemical nature (Li and Vert 2002). Naturally sourced
lactic acid undergoes condensation polymerization in order
to produce PLLA (Zhang 2015). Poly (L-lactide) is bio-
degradable, biocompatible, non-toxic, semi-crystalline poly-
ester, which forms a blend of amorphous and crystalline
phases upon solidification; the proportion of these fractions
is defined by the thermal and deformation history during
processing within the PLLA structure (Quynh et al. 2007;
Ormiston et al. 2008; Foin et al. 2014). Mechanically, it has
a high tensile strength which makes it an ideal material for
use in load-bearing applications (Weir et al. 2004), though
raw polylactic acid, a glassy polymer, has a moderately low
strength and poor elongation at break. Chemical modifica-
tions, blending with other polymers and control of polymer
chain orientation are amongst methods used to improve
polymer’s mechanical properties and tailor its resorption
rate (Grijpma et al. 2002; Pruitt and Chakravartula 2011;
Foin et al. 2014). The radiolucent material is a clinically
approved material, and illustrated to be safe in human cor-
onary arteries (Tamai et al. 2000; Ormiston and Serruys
2009; Yang and Fernandez 2015). At room and physio-
logical temperatures, PLLA is in a solid state as it is below
the glass-transition temperature (Tg). Table 3 illustrates
typical properties of PLLA; however these can vary with
parameters of manufacturing processes such as annealing
temperature, extrusion method and blow moulding
(Ormiston et al. 2008; Yang and Fernandez 2015). Variation
of its elastic modulus with different manufacturing pro-
cesses, is presented in Table 4. T4
Mechanical testing of PLLA for use in cardiovascular
interventions
Due to strict guidelines, which stent manufacturers must
adhere to, there is an obligation for them to provide per-
formance evidence for manufactured scaffolds. This, in
turn, assists with further development of devices as well as
a wider spread of device approval and clinical use. There
are various techniques and guidelines, which can be
employed to mechanical tests of stents, including three-
point bending (ASTM F2606; ASTM 2014a), radial force
testing (ASTM F3067; and a specific set of guidelines for
testing of absorbable stents (ASTM F3067)(ASTM 2013).
Table 3 PLLA properties (Röhm and Aldrich; Tamai et al. 2000;
Hoffmann and Mintz 2000; Zhang 2015)
Property Value
Melting temperature – Tm (°C) 170–190
Transition temperature – Tg (°C) 50–65
Tensile strength (MPa) 50–70
Crystallinity (%) 37
Young’s modulus (GPa) 2.7–16
Elongation at break (%) 30–40
Table 2 Comparison of BRS with other angioplasty techniques/
devices (Iqbal et al. 2014)
POBA BMS DES BRS
Acute occlusion − + + +
Acute recoil − + + +
Acute thrombosis − − − −
Sub-acute thrombosis ± − − −
Late thrombosis + − − ±
Very late thrombosis + ± −/ ± +/?
Neointimal hyperplasia − − + +
Constrictive remodelling − + + +
Adaptive (expansive) remodelling + − − +
Restoration of vasomotion + − − +
Late luminal enlargement + − − +
[POBA - plain old balloon angioplasty; BMS - bare metal stent; DES - drug
eluting stent; BRS - bioresorbable scaffold; + − positive/beneficial; − -
negative/ no effect; ± − neutral or uncertain effect;? - lack of definitive
evidence] No with direct comparison study of four techniques therefore, the
table is compiled based on non-comparative data (Iqbal et al. 2014)]
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The last document detail securement of a vascular stent
onto a delivery system, three-point bending of the whole
device and a method to measure its intrinsic recoil. How-
ever, these methods do not assess evolution of mechanical
performance of stents with degradation. It is worthwhile
to mention that testing of the bulk material may not pro-
vide mechanical data suitable for devices due to changes
caused by manufacturing and processing conditions when
this bulk material is transformed into a tubular scaffold
with fine details at a scale of 100 μm. According to the lit-
erature there are no guidelines for measurements of the
mechanical performance of polymeric scaffolds with deg-
radation and analysis of their local mechanical properties
(i.e., for varying locations across the scaffold). It is also im-
portant to note that in-vitro testing is not representative
of the in-vivo environment, though it does allow for more
comprehensive data for computational studies. In the sub-
sequent sections, methods used by different research
groups to characterize stent performance mechanically by
taking into consideration the effect of manufacturing pro-
cesses on material properties are reviewed. Experimental
conditions in-vitro are also discussed, along with degrad-
ation behaviour of PLLA.
Effect of processing on mechanical properties
Agrawal et al. (1992) performed one of the first studies
investigating the mechanical properties of PLLA for use
in vascular stents, specifically looking at the effects of
processing. Elastic and shear moduli for PLLA fibres
subjected to higher draw ratios were investigated. Stent
cohorts were synthesized from PLLA monofilaments,
each with varying draw ratios. The elastic modulus and
UTS were found to increase with draw ratios of the
monofilaments; however, this caused a decrease in the
shear modulus and elongation at break. Such alterations
in properties are related to an increased degree of longi-
tudinal molecular orientation caused by drawing. Mono-
filaments for each draw ratio were then split in three
groups; control, annealing at 140 °C (constrained) and
unconstrained annealing at the same temperature. Con-
strained annealing, with the ends of the monofilaments
fixed, gave enhanced elastic and shear moduli compared
to the control group. The main outcome of this research
was the link between the mechanical properties of the
PLLA monofilament and the draw ratio and thermal his-
tory. Fambri et al. (1997) corroborated this research by
assessing PLLA fibres produced by melt spinning. Pro-
cesses such as extrusion and hot drawing contributed to
the decline in molecular weight of a material. Gupta et
al. (Gupta et al. 2007) presented a comprehensive over-
view of PLLA fibres, including the variety of production
methods and the correlation between their structure and
properties. With regard to their use in medical applica-
tions, e.g. stents, it was noted that tailoring the micro-
structure enabled modification of mechanical properties
of scaffolds. It was stated that due to the limitations of
material properties of PLLA (weaker mechanical proper-
ties compared with metals used in stents and more brittle
nature) polymeric modifications, blending with other
polymers and producing micro−/ nano-composites of
PLLA could overcome these challenges (Madhavan
Nampoothiri et al. 2010).
Grabow et al. (2005) assessed micro-specimens of
PLLA to quantify the effect of laser machining and
sterilization techniques on mechanical properties, with a
comparison made between pure PLLA and PLLA with
plasticizer. Dimensions of samples, (although not in the
form of cylinder), were adapted to match the strut size
of polymer scaffolds. Plasticizer incorporation signifi-
cantly enhanced the elongation at break of the PLLA
polymer, which would enable accumulation of higher
maximum strain without strut rupture compared to pure
PLLA; however the adverse effect was observed for
creep behaviour of the material. Grabow et al. (2005)
clearly demonstrated that processing conditions should
not be disregarded when selecting a suitable material for
stenting applications. Annealing is a secondary process,
wherein the material is brought to a certain temperature,
kept there for some time and then cooled down to room
temperature. The main aims of for annealing include the
reduction or removal of residual stresses and strains, di-
mensional stabilization, reduction or elimination of de-
fects and improvement of physical properties (LeGrand
2011). This process was found to have a significant effect
on mechanical properties of PLLA samples where, gener-
ally, a higher annealing temperature resulted in a polymer
with higher crystallinity and a more ordered crystalline
phase (Renouf-Glauser et al. 2005; Welch et al. 2008). This
reiterates that material processing conditions affect signifi-
cantly mechanical properties (Perego et al. 1996; Sarasua
et al. 2005).
A review by Bergstrom and Hayman (2016) concluded
that PLLA, like other bioresorbable polymers, demon-
strated highly non-linear mechanical behaviour. This
was attributable to strong effects of temperature, mo-
lecular weight, molecular orientation, crystallinity and
physical ageing characteristics on properties, which
Table 4 Variation of PLLA elastic modulus with manufacturing
method
Reference Sample shape Manufacture
method
Elastic
modulus (GPa)
Weir et al.
(2004)
Dog bone Compression
moulding
0.62
Grabow et al.
(2005)
Dog bone Laser cut 2.85
Leenslag et al.
(1984)
Fibres Dry-spinning /
hot-drawing
11.4
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could be tailored through material processing. The paper
highlighted a link between the Young’s modulus and
elongation to failure at room temperature for a range of
PLLA materials with varying microstructure. So the pro-
cessing history of the PLA material must be considered
prior to extrusion into a scaffold (Fig. 3).
Experimental testing on virgin PLLA samples
Specimens for testing of materials for bioresorbable scaf-
folds come in a variety of forms from fibre to dogbone
and the whole scaffold. Thus, each set of data is specific to
the used configuration and does not represent general
PLLA behaviour. With complex scaffold geometries, it be-
comes apparent that there is no simple way to test com-
plex mechanical behaviour, especially in localized areas.
Zilberman et al. (2005) assessed behaviour of PLLA fibres
and stent structures by subjecting them to uniaxial tensile
testing. PLLA revealed high levels of tensile strength and
modulus in comparison to other biodegradable polymers
tested, polydioxanone (PDS) and poly(glycolide-co-epsilon-
caprolactone) (PGACL) (Table 5). From Fig. 4, it is appar-
ent that PLLA is the only polymer which exhibits yield.
Engels et al. (2009) assessed the performance of
amorphous PLLA materials under short- and long-term
static loading conditions to investigate the time-
dependent failure behaviour, especially the molecular
and kinetic mechanisms which cause this time depend-
ence. They found that premature failure seen in polylac-
tides was due to the time-dependent behaviour of the
materials, a common feature of polymer materials. The
work assessed compression behaviour of PLLA under a
range of applied strain rates. As illustrated in Fig. 5a,
PLLA initially behaved as a linear viscoelastic material,
and changed to a non-linear response with increasing
stress levels. A yield point of the material appeared at
around 4% strain level with stress of 94 MPa. The initial
response exhibited the trend for a typical brittle material,
a dominant characteristic of PLLA, but strong softening
(decreasing stress with increased strain) was followed by
some hardening (upward trend of stress versus strain
and large stretching before failure) (Meijer and Govaert
2005). Creep deformation of PLLA (Fig. 5b) is charac-
terised by a sudden increase in strain to the point of
final failure, which happened after some 30 min of the
application of the stress equal to 70% of the yield point
(Engels et al. 2009). An additional factor, which may
affect the time-dependent performance of PLLA, is the
application of dynamic load caused by blood pressure.
Bobel et al. (2015) recently characterized pre-degradation
characteristics of PLLA used for cardiovascular application,
as there remained a lack of data in this area. Performance
of PLLA was strongly dependent on temperature and strain
Fig. 3 Overview of the summarizing link between Young’s modulus and material microstructure (Agrawal et al. 1992; Perego et al. 1996; Wang et
al. 1998; Middleton and Tipton 2000; Hermawan et al. 2010; Sin et al. 2012; Söntjens et al. 2012; Deroiné et al. 2014; Nerkar et al. 2014; Bergstrom
and Hayman 2016)
Table 5 Mechanical properties of bioresorbable fibres obtained
in tension testing (Zilberman et al. 2005)
Fibre Tensile strength (MPa) Modulus (MPa) Strain (%)
PLLA 967 5000 50
PDS 583 367 161
PGACL 721 477 151
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rate, and overall strain was revealed to contain a significant
recoverable component. These factors were demonstrated
at a displacement rate recommended for Absorb scaffolds
(Abbott vascular, U.S.A.) [2.5 mm/min] (Fig. 6), which
is the suggested inflation rate for scaffold deployment
(Abbott Absorb and Absorb GT1, 2016). Work by
Wang et al. (2017) presented uniaxial tensile tests on
high molecular weight PLLA at two temperatures in
order to correctly replicate mechanical behaviour of
stent crimping (48 °C) and expansion (37 °C – body
temperature) (Fig. 7). The obtained results demonstrated
good plasticity of the material and a steady state of stress
evolution in the material after yield stress was reached.
The testing schemes employed mostly two types of
specimens- fibres and dogbone samples make of bulk
material. Obviously, these specimens, generally, were not
exposed to the same manufacturing/ processing condi-
tions as a whole scaffold, questioning the suitability of
obtained results to analysis of scaffolds. To overcome
these limitations, post-manufacture tests of scaffolds
were performed.
Scaffold testing
Testing the macro properties of a scaffold is difficult to
pursue due to their intricate geometry. At present, there
is one set of ASTM guidelines for testing of absorbable
stents (ASTM 2013) but they do not capture mechanics
of the whole device before and during implantation and
degradation. Eswaran et al. (2011) carried out a ring-test
experiment, using Absorb scaffold, to quantify its mech-
anical data. Geometry of the ring was non-uniform
around the circumference; therefore, it could be as-
sumed that, due to this, mechanical properties of the
scaffold differed around the ring. The ring-tension ex-
periments showed a breakage just below 3 N (Fig. 8a).
To ensure the material tested was comparable to that of
final stent, dog-bone samples used for tension testing
were subjected to manufacturing processes that a scaf-
fold tube would undergo. Figure 8b illustrates material
anisotropy after yield and the flow resistance in the cir-
cumferential direction continues to grow post yield;
however, in the axial direction, there was a weaker
Fig. 4 Stress-strain curves for different bioresorbable fibres
(Zilberman et al. 2005)
Fig. 5 (a) True stress versus strain (compressive) at constant strain rate; (b) evolution of compressive true strain with loading time at constant
stress (Engels et al. 2009)
Fig. 6 Experimental stress-strain behaviour with maximum displacement
of 50% at different temperatures (RT, BR & HT are room, body and high
temperatures respectively) (Bobel et al. 2016)
Naseem et al. Mechanics of Advanced Materials and Modern Processes  (2017) 3:13 Page 7 of 18
response with necking occurring. The displacement rate
for testing is also shown to have an influence. Typical
for PLLA, the material response was found to be strain-
rate-dependent.
Oberhauser et al. (2009) investigated the Absorb scaffold
by considering change in radial strength and molecular
weight over time with incubation up to 90 days. It can be
seen that Absorb stents had a radial strength comparable
to that of common metallic stents (Fig. 9). This is despite
weak bulk mechanical properties of polymers in compari-
son to their metallic counterparts and due to post-
extrusion manipulations with polymeric tubes increasing
the circumferential orientation of crystallites in the semi-
crystalline PLLA structure, resulting in higher resistance
to radial loading (Oberhauser et al. 2009).
Additional data for Abbott Vascular stents (Fig. 10)
show the evolution of pressure against the scaffolds’
outer diameter with degradation times, obtained by
using a MSI RX550 Radial Force tester. The data show a
noticeable change in behaviour with the onset of plastic
deformation. For periods shorter than 12 months, the
scaffold plastically deformed under larger compressive
loads. However, it was still able to maintain radial sup-
port to the artery beyond the yield point. For implant-
ation longer than 12-months, a reduced resistance of
stents to compressive load was found, indicating a lack
of integral support to a vessel wall. This testing strategy
is essential to observe maintenance of vessel patency is
maintained during critical months of vessel healing
(Kossuth et al. 2017).
Other features also affect mechanical properties of
PLLA stents. Gomez-Lara et al. (2011) investigated the
variation in curvature and angulation of the treated vessel
post-deployment of BRSs. Absorb, in comparison to metal-
lic stents, presented better conformability to vessel’s
Fig. 7 Stress – strain curves for PLLA at crimping and expansion
temperatures (Wang et al. 2017)
Fig. 8 (a) Average force-displacement average curves from ring-tension experiment; (b) stress-strain data for uniaxial tension (1 – circumferential-fast;
2 - circumferential-medium; 3 – circumferential-slow; 4 – longitudinal-fast; 5 – longitudinal-medium; 6 – longitudinal-slow) (Eswaran et al. 2011)
Fig. 9 Radial strength data for polymeric and metallic stents
(Oberhauser et al. 2009)
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architecture and produced lower variations of these param-
eters (Gomez-Lara et al. 2010). In 2011, the same authors
demonstrated that BRS restored coronary configuration in
comparison with metallic stenting which altered geometry
permanently (Gomez-Lara et al. 2011). Foin et al. (2016)
assessed overexpansion of Absorb scaffolds beyond their
recommended diameter and concluded that this could
result in strut breakage and a loss of central mechanical
support. A similar work was conducted and corroborated
by Ferdous et al. (2015).
A comprehensive overview of in-vitro tests assessing
mechanics associated with the safety and efficacy of the
implantable devices was presented by Schmidt et al.
(2016). Scaffold expansion, elastic recoil, radial strength
and flexibility/ bending stiffness were assessed for two
types of virgin bioabsorbable scaffolds and one metallic
stent. As expected, the Absorb scaffold demonstrated
lower crush resistance in comparison to a metallic stent;
however, the collapse pressure for Absorb (172 kPa) was
in the required range for radial strength of permanent
stents (Fig. 11; Lanzer and Schmidt 2015). This data cor-
roborates with that produced by Oberhauser et al.
(2009), where strength of polymer scaffolds was compar-
able to that of their metallic counterparts. Elastic recoil
of the stents was assessed immediately after implant-
ation and an hour after expansion in two vessel types,
i.e., rigid (Fig. 9b) and mock vessels (Fig. 9c). Within the
rigid vessel, the Absorb scaffold exhibited recoil compar-
able to that of BIOTRONIK; however, it did not display
the interesting behaviour of DESOLVE, whose diameter
increased after an hour. The mock vessel did not affect
the BIOTRONIK stent, but encouraged further recoil of
the Absorb scaffold after an hour of implantation and
significantly increased recoil of the DESolve scaffold.
These results illustrate that it is crucial to correctly simu-
late in-vivo conditions as they may impact a stents per-
formance. With load, the Absorb scaffold did recoil
further, as expected. The authors noted that good in-vitro
performance would not always correlate to good perform-
ance in-vivo, and poor in-vitro performance is indicative
of potential complications. These obtained results showed
the high performance of PLLA and, in particular, the Ab-
sorb scaffold in comparison to metallic counterparts.
Mechanical performance of scaffolds with degradation
Obviously, in-vitro degradation of bioresorbable stents
has a strong effect on their mechanical properties and
Fig. 11 (a) Radial strength measured as a means of collapse pressure; acute and time dependent recoil after expansion in (b) a rigid vessel
model and (c) in a mock vessel (Schmidt et al. 2016)
Fig. 10 Pressure vs. outer diameter post-deployment for samples
with varying degradation times (Kossuth et al. 2017)
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performance. Degradation is defined as the “chain-scis-
sion process, during which polymer chains are cleaved to
form oligomers and, finally, to form monomers”, whereas
erosion “designates the loss of material owing to mono-
mers and oligomers leaving the polymer” (Göpferich
1996). There are two methods of hydrolysis which
PLLA can undergo: (1) chemical degradation via hydrolysis
and (2) enzyme-catalysed hydrolysis; the former is the most
prominent for artificial biodegradable polymers. Degrad-
ation of polymers such as PLLA depends on parameters of
the environment, only some of which are controllable; these
include the type of chemical bond, pH level, molecular
weight, polydispersity, crystallinity, morphology, ionic
strength, temperature and water uptake (Göpferich 1996;
Gong et al. 2007; Zhang 2015).
Degradation of PLLA fibres in vitro were investigated by
Yuan et al. (2002) with fibres incubated in phosphate
buffer solution (PBS) with pH 7.4 and at 37 C for 35–
45 weeks. The average molecular weight of fibres, pro-
duced by melt spinning, dropped throughout degradation,
with 40–60% reduction at the end of the incubation
period and an increase in crystallinity. Fibres studied by
the group were not investigated separately, instead, they
were bundled together randomly which may have affected
their biodegradation. PBS was changed fortnightly which
is an acceptable time frame in accordance with ASTM
standards. Prior to measurements of degraded samples, a
bundle was removed from PBS, washed with water and
dried in a vacuum oven at 48 C. Water absorbed by the fi-
bres is a potential issue that could affect the results of this
scheme. However, authors did not mention duration of
this process. Additionally, drying in a vacuum oven is a
good methodology to remove excess fluid from the fibres;
however, a temperature of 48 C could affect the properties
of the fibre, with potential to cause damage to the
polymer. The group could have weighed fibres prior
incubation in the vacuum oven in order to assess the
water content in the material (Yuan et al. 2002).
Mechanical, rheological, fatigue and degradation behav-
iour of PLLA used in vascular implants was investigated
by Bartkowiak-Jowsa et al. (2012). The authors highlighted
the importance of adequate optimization of stent design.
The study produced results (Fig. 12) confirming the need
to change the incubation fluid at regular intervals. A saw-
tooth character of the graph demonstrates that the incu-
bation fluid required regular replenishment to maintain a
pH of 7.4 ± 0.2. PLLA tested in this regime did not show
a decrease of more than 10% in strength and deformabil-
ity, ideal for providing sufficient support for an arterial
wall. However, it was noted that the total degradation time
for PLLA was 24 months, far beyond the time required
for tissue regeneration. In order to combat this, the au-
thors suggested the modification of PLLA through the
addition of biodegradable filler, alginate fibres. These
fibres enhance liquid absorption at phase boundaries
resulting in faster degradation, without affecting mechan-
ical properties of PLLA. The study assessed the stability of
elastic properties by testing their thermodynamic proper-
ties. Assessing the storage-modulus values allowed the au-
thors to determine the temperature range, in which the
material demonstrated the desired elastic properties. All
materials tested had glass-transition temperatures in the
range of 56.1–68 C providing structural stability in the
temperature range of biomedical applications.
Kimble and Bhattacharyya (2015) assessed mechanical
properties of PLLA during in vitro degradation in com-
parison to a co-polymer material (PLLA/PBS) by incu-
bating dogbone specimens for 24 weeks in PBS at 37 °C.
In comparison to the co-polymer tested, neat PLLA
maintained integrity throughout 24 weeks, showing in-
creasing creep resistance in the initial 8-week degrad-
ation period. The initial modulus and tensile strength of
PLLA are higher than those of a variety of co-polymer
blends. The study demonstrated the necessity to obtain
baseline properties of a material and that the co-
polymeric blend in fact had lower mechanical properties
and a higher, less stable degradation rate. The effect of
fatigue on chemical and mechanical degradation of
model stent sub units was analysed by Dreher et al.
(2016) since this factor can impact greatly on a stent's
performance and was studied insufficiently. Subunits
composed of PLLA were exposed to fatigue and degrad-
ation conditions simultaneously, amounting to one year
of implantation within the body. Preliminary experi-
ments, carried out by the authors, illustrated that 38
million fatigue cycles were concurrent with one year of
implant of the scaffold within a pulsatile vessel. In com-
parison to control samples tested under static conditions
(i.e. without fatigue), the study indicated that fatigue
loading, resulted in a significant increase of samples
stiffness with a diminished force at break. Molecular
Fig. 12 Evolution of pH of PLLA incubation solution over time
(Bartkowiak-Jowsa et al. 2012)
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weight was also affected, with a greater decline seen at
fatigue. The authors concluded that this illustrated a link
between chemical degradation and mechanical loading.
The effect of degradation on tensile mechanical prop-
erties of PLLA fibres and expandable stents prepared
from fibres was studied by Zilberman et al. (2005). The
work discovered that PLLA, in contrast to other bioab-
sorbable materials, underwent degradation at a slower
rate, displaying no alterations in mechanical properties
during 6 weeks (Fig. 13). It also confirmed results of
the previous study by the same group, showing PLLA
fibres exhibited good mechanical properties after
24 weeks of degradation incubation (Zilberman et al.
2004). Single fibres constructed into a stent structure
for each polymer were subjected to radial compressive
tests (Fig. 14) to obtain data for scaffold strength.
PLLA showed consistent results over the 6-week
period and confirmed its viability for use as an arter-
ial support structure.
Dreher et al. (2015) focused on assessing the process
of degradation of PLLA tubes in in-vivo tests as a model
for coronary stent degradation. Their predominant aim
was to estimate the effect of physiological factors, (pulsa-
tile flow, body temperature), in testing of scaffolds. Their
work demonstrated that PLLA tubes subjected to mock
pulsatile flow displayed a statistically different degrad-
ation pattern to tubes subjected to control conditions
(inside the vessel but not subjected to pulsatile flow).
The results indicated that to correctly investigate per-
formance of polymeric scaffolds in-vivo, all constituents
that stimulate degradation such as correct pulsatile flow,
pressure, and temperature should be implemented in-
vitro to obtain accurate results. After 6 months, it was
seen that the scaffold in the loop set up presented a
slower rate of molecular weight loss compared to the
control samples. This was potentially due to oligomers,
breakdown products from degradation, being removed
with the flow system (as opposed to remaining within
the control samples), creating localized degradation be-
cause of their acidic nature. Crystallinity changes for
control samples were comparable; however, the loop
samples showed that crystallinity was diminished signifi-
cantly. This was accounted for by the group by relax-
ation of polymer chain with certain stimuli such as
frequency and temperature (Fig. 15; Dreher et al. 2015).
The effect of static and dynamic loading conditions
on degradation of PLLA stent fibres was assessed by
Hayman et al. (2014) over 15 months to ascertain
whether dynamic conditions were required during in-
vitro testing and it was found that it did affect output.
In comparison to a static load, dynamic load seemed to
accelerate degradation, especially at later time point;
however an increase in static load also showed acce-
lerated degradation (Hayman et al. 2014). Luo et al.
(2014) assessed the degradation performance of high-
molecular-weight PLLA scaffolds in a mock artery
system. A plasma pump enabled simulation of systolic/
diastolic pressures comparable to those observed in the
human circulatory system. The system also enabled in-
corporation of fluid circulation to mimic blood flow.
These data were compared to in-vivo results, where the
scaffolds were implanted into animal models. There was a
good correlation between the in-vivo and in-vitro results,
and the slight discrepancies between the two conditions
Fig. 13 Mechanical properties of 3 bioresorbable polymers subjected to degradation in phosphate buffer solution (PBS) at 37 °C: a tensile
strength; b Young’s modulus; c strain (Zilberman et al. 2005)
Fig. 14 Radial compression tests for scaffolds comprised of single fibres
(PLLA (squares), PDS (circles) and PGACL (triangle) (Zilberman et al. 2005)
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might be attributed to the biochemical environmental dif-
ference (Luo et al. 2014).
From this review of degradation, manufacturing and
processing studies for PLLA, it can be concluded that a
significant number of factors affect mechanical proper-
ties of PLLA scaffolds, from its initial post-implantation
state and throughout degradation. Each PLLA material,
depending on these conditions, can result in significantly
altered mechanical properties and degradation profiles.
Degradation performance of biodegradable polymers in-
vitro showed that higher loads resulted in shorter deg-
radation times (Athanasiou et al. 1998;,Middleton and
Tipton 2000); therefore accurate simulation of mechan-
ical conditions corresponding to real-life conditions (e.g.,
pulsatile flow and loads) is needed. Additionally, many
studies appeared to use PBS as a fluid to incubate scaf-
folds; however, the biochemical environment may also
influence polymer degradation. Obtaining accurately
quantified mechanical response data can then be used as
input into a constitutive model for finite-element (FE)
simulations (Bobel et al. 2016). This could diminish ex-
perimental efforts and enable accurate prediction of
scaffold performance throughout its lifecycle.
Computational studies for BRS performance with
degradation
Numerical simulations, based on adequate mechanical
models allow additional insights into a response of a
physical system to specific loading and environmental
conditions that can be used for making decisions from an
engineering perspective (Babuška 1991). Computational
modelling of medical devices enables the users to obtain
knowledge of their performance and precise locations of
failure in a device, implement design optimization and
reduce benchtop testing thus minimizing the device
development time and cost (Eswaran et al. 2011; Bobel et
al. 2015). The ability to accurately capture the behaviour
of medical-device materials under physiological loads and
during processing remains a challenge. There appears to
be a lack of material models detailing the accurately the
degradation process of bioabsorbable materials because of
a wide range of factors affecting on a materials response,
e.g., temperature, processing and extrusion procedure.
Simulations run with FE analysis for complex loading con-
ditions require precise experimental investigation into the
modelled material in order to obtain fundamental geomet-
ric and material parameters (Bobel et al. 2015). Through
development of accurate validated computational models,
high-quality predictions of device performance are pos-
sible (Eswaran et al. 2011). Due to the complexity and lim-
ited work carried out in the area of numerical simulations
of PLLA BRSs, this section highlights the recent studies.
Material modelling of PLLA
Mechanically, PLLA is an anisotropic, viscoelastic material,
with its response characterized by rate-dependent visco-
plasticity (Eswaran et al. 2011). This time-dependent behav-
iour of the material is also influenced by temperature,
surrounding environment and processing conditions,
commonly observed in polymers (Grabow et al. 2005).
Given these varying factors, it is critical that material
characterization and responses of its specimens and entire
Fig. 15 Experimental set up and results from work conducted by Dreher et al. (2015)
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devices are adequately captured by the model to provide
accurate predictions. At low strains, the behaviour of this
material is viscous whereas under high strain, it behaves as
brittle elastic material (Bardenhagen et al. 1997). A non-
linear mechanical response of PLLA is due to its low glass-
transition temperature (Tg = 60 °C), sensitivity to molecular
weight, degree of crystallinity and physical ageing time
(Bergstrom and Hayman 2016). Classical linear viscoplas-
tic/elastic models therefore cannot be used to describe
PLLA behaviour as they do not capture its full anisotropic
behaviour (Eswaran et al. 2011). Also typical elastic, hypere-
lastic or viscoelastic models are not able to capture the ac-
cumulation of plastic strain in a material, which is crucial
for engagement of vascular scaffolds (Vieira et al. 2015).
Neo-Hookean or Mooney-Rivlin models, describing
incompressible hyperelastic materials, could be used to
predict material behaviour prior to any fissure of non-
degraded PLLA. These models are useful as they can pre-
dict monotonic behaviour of PLLA devices, also at specific
degradation time points. Mechanical behaviour of PLLA,
with large deformation and dynamic loads at different
strain rates, is both viscous and elastoplastic. Also, hyster-
esis behaviour was observed in biodegradable polyesters
(Vieira et al. 2015). A handful of models at present ac-
count for diverse behaviours of aliphatic polyester using
varying combinations of hyperelastic, viscous and plastic
models; however, they do not account for the degradation-
related changes (Vieira et al. 2015). As scaffolds are sub-
jected to loading above the elastic limit during processing/
manufacturing, it leads to an accumulation of plastic strain
and contributes to device failure at these areas of high
strain. Post-implantation scaffolds are also subjected to a
cyclic stresses, which could cause evolution of significant
plastic strain during their in-service life resulting in failure
and laxity (Vieira et al. 2015). Hydrolysable bonds in PLLA
make the material more susceptible to moisture, heat, light
and mechanical stresses. The traditional degradation
mechanism of biodegradable polymers is chemical degrad-
ation via hydrolysis or enzyme-catalysed hydrolysis. Im-
portantly, mechanical behaviour of the material evolves
with time due to the hydrolytic chain scission (Pan 2015).
Degradation results in a reduction in molecular weight of
such polymers, there is also a reduction in its ductility,
toughness and strength (Vieira et al. 2015). Some complex
material models based on a concept of networks, combin-
ing elastic, sliding and dissipative elements (based on
Boltzmann’s superposition principle), are used to simulate
this time dependent response; however, most models only
simulate an initial mechanical response of the polymer
and neglect changes in material properties during hydro-
lytic degradation (Vieira et al. 2015).
Constitutive material models
Tailoring microstructural parameters for specific functions
are depends on potential applications; these parameters
can be controlled with resin formulation and processing
conditions. Stress-strain, deformation and degradation re-
sponses of a material is affected significantly by a type of,
and changes in, applied boundary conditions, loads and
environmental factors, the material is subjected to. Such
multi-physics responses can be incorporated into relevant
constitutive models to simulate material behaviour; how-
ever, there remains doubts as to whether a whole-device
response is accurately captured in simulations (Bergstrom
and Hayman 2016). A stent technology and mechanical
behaviour of metallic stents are relatively well established;
however, due to the non-linear, viscoplastic and degrad-
able behaviour of PLLA along with an altering mechanical
response of the device in-vivo, the performance of BRSs
with degradation is not as established (Bergstrom and
Hayman 2016). The ideal material model for the Absorb
PLLA scaffold should be able to capture the nature of the
mechanical properties of the stent with evolving degrad-
ation. As highlighted in Table 6, numerous materials
modes were proposed in literature to capture complex re-
sponses of biodegradable polymers - from their virgin
state right through to full degradation (Soares et al. 2008,
2010a, b; Eswaran et al. 2011; Muliana and Rajagopal
2012; Khan and El-Sayed 2013; Vieira et al. 2015; Rosa et
al. 2016). The past five years have seen significant ad-
vancements in computational mechanics of bioresorbable
scaffolds aimed at development of material models to cap-
ably simulate adequately performance of PLLA stents.
Computational and mathematical modelling of BR
scaffolds
Various groups of researchers concentrated on different
aspects of simulation of properties and performance of
Table 6 Different material model frameworks used for modelling of PLA (Soares et al. 2008; Eswaran et al. 2011; Söntjens et al. 2012;
Khan and El-Sayed 2013; Hayman et al. 2014; Bergstrom and Hayman 2016)
Model Class Degradation modelled Visco-plastic effects Anisotropic effects Use in FE simulations
(Eswaran et al. 2011) Viscoplastic x ✓ ✓ ✓
(Hayman et al. 2014) Hyperelastic ✓ x x ✓
(Khan and El-Sayed 2013) Linear viscoelastic ✓ x x ✓
(Soares et al. 2008) Hyperelastic ✓ x x ✓
(Söntjens et al. 2012) Viscoplastic ✓ ✓ x x
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bioresorbable stents. Bobel et al. (2015) compiled a com-
prehensive study of computational bench testing using
Abaqus/Standard 6.12 (SIMULIA), to evaluate short-
term mechanical performance of three different stent
designs; however, with no consideration for polymeric
degradation. A non-linear viscoelastic parallel network
model was used to account for material performance;
still, there was no account for materials plasticity. Whilst
some more complex material representations are avail-
able, the group discussed the advantage of this model,
including its ease of use and access in Abaqus software,
which captures PLLA behaviour for the testing method-
ologies involved sufficiently well. An interesting notion
is a “flexible” material model, where a range of elastic
behaviours and properties of PLLA can be incorporated
in it. Still, this model is only suitable for material behav-
iour at so called “time zero” (i.e. immediately post de-
ployment). A strong feature of this work is the use of
real stent geometries and experimental testing to assess
the radial strength, flexibility and longitudinal resistance
(Fig. 16). Additionally, shorter sections of stents were
used, 2 or 4 circumferential rings, to reduce the compu-
tation time. There was a special focus on ensuring that
the stents were exposed to the same real-life processes
prior to implanting (e.g. expansion). Authors found that
to meet the requirement of minimum collapse pressure
of 0.04 MPa, the Young’s modulus of 4.1 GPa was re-
quired for Absorb scaffolds. This was conflicting infor-
mation based on an Abbott patent report, stating that
PLLA has a modulus of 1.2–2.7 (Wang 2013). So, it
would have been more accurate to accommodate this
range of values in the employed material model. The ra-
dial strength of the Absorb scaffold was reported to be
comparable to that of metallic stents (Oberhauser et al.
2009), so long as they were deployed within their size
limits, these experimental data contradict the computa-
tional results of this work. It was suggested that to im-
prove the radial performance of stents, the materials
elastic modulus should be increased to 15 GPa. This, how-
ever, would affect the compliance mismatch which is a
goal for bioresorbable scaffolds (Brugaletta et al. 2012).
According to this study, the wide variations in the poly-
mer’s elastic modulus resulted in a corresponding range of
stent resistance to applied pressure, with weaker materials
prone to collapse under lower pressure. Additionally, strut
thickness was assessed computationally and it was found
that as in the experiments, thicker struts could bear higher
radial pressure than thinner struts. Finally, assessing a
range of stent geometries, the mechanical performance of
scaffolds was directly linked to their design and dimen-
sions (Bobel et al. 2015). Schiavone and Zhao (2016) cor-
roborated the factor emphasised in Bobel et al. (2015),
that it is essential relevant biomechanical forces in the
model are incorporated in computation performance
studies in order to correctly simulate all steps of a scaffold
lifecycle, from manufacturing to full degradation.
In another study Luo et al. (2014) conducted compre-
hensive in-vitro and in-vivo analysis to validate their
model by employing a user-defined constitutive model
(USDFLD) in FE simulations. In this approach a user can
manually define different field variables in order to ac-
count for material properties at a certain time point. In-
corporating varying degrees of degradation into the
material model enabled assessment of evolution of stent
properties with time. Numerical simulations were carried
out using Abaqus, with C3D8I element used to mesh the
geometric model. This incompatible-mode eight-node
brick element was preferred to model stents with Abaqus
as they are loaded predominantly in bending (Pham et al.
2014). Crimping and expansion tools were meshed with a
surface element (SFM3D4R) and scaffold simulation car-
ried out in four steps (Table 7). These steps were neces-
sary to assess the forces the scaffold is exposed to prior to
its implantation into an artery. A fatigue simulation was
also conducted to ascertain the effect of pulsatile flow on
the change in mechanical properties with time. In this
simulation, the last effect was incorporated by application
of pressure to the inner arterial walls. This stage was
followed by simulations of the degradation process.
Figure 17a demonstrates the von Mises stress for crimp-
ing to 1.5 mm (A) and expansion (B). Stresses were local-
ized in the U-bend regions of the scaffold, common for
polymeric stents (Schiavone et al. 2017). The stage of
elastic recoil saw a stress decrease from 161 MPa to
102.4 MPa. In expansion, stress concentration was again
found in the U-bend regions, with a high tensile stress of
Fig. 16 Computational bench tests (Bobel et al. 2015)
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172.3 MPa. The degradation process was assessed post-
fatigue, thus ensuring the material state was as in-vivo,
with a similar application of biomechanical forces. It was
observed that degradation occurred at a greater rate in
areas of previous higher strain, presenting spatially non-
uniform degradation throughout the scaffold (Fig. 17b).
Performing expansion on the incubated in-vitro scaffolds,
the observed areas of breakage coincided with high-
concentration areas obtained with FE. Thus, the in-vivo,
in-vitro and FE results were consistent, implying suitabil-
ity of the material model used.
Similar to Luo et al. (2014), Wang et al. (2017) pre-
sented a combined experimental and computational
study on the mechanical performance of PLLA coronary
implants. To implement computation aspect, the Aba-
qus/ Standard implicit solver was used to estimate radial
strength and 3-point-bending performance of stents,
with care taken to adhere to ASTM standards to ensure
that simulations were as close to the testing protocol as
possible. Model geometry closely mimicked that of Ab-
sorb, and a mesh of hexahedral C3D8R elements was ap-
plied. In comparison to Luo et al. (2014), the crimping
and expansion simulations also incorporated the effect
of temperature for each of these stages, i.e., crimping
was at 48 °C and expansion at body temperature 37 °C.
This was supported by testing pure PLLA at different
temperatures and using the obtained data with respect-
ive models. Results were acquiescent with those de-
scribed by Luo et al. (2014); with localization of stress
found in U-bends of the scaffolds. Simulations were reli-
ant on the experimental data obtained by the group for
crimping, expansion, radial strength and three-point
bending. Table 8 presents the correlation between the
obtained in-vitro data and computational results. For
crimping, the radial recoil ratio was not as critical as
that observed for expansion. By over-expanding scaf-
folds, apparently, recoil was reduced, indicative of plastic
deformation in the material. These findings can be used
to ensure a suitable recoil effect to prevent mechanical
injury to the vessel wall due to excess expansion, result-
ing in inflammation.
In comparison to Wang et al. (2017), Pauck and Reddy
(2015) simulated the radial performance of PLLA stents
within a remodelling artery, taking into consideration vari-
ous geometries for the scaffolds. Material-characterization
tests were conducted to obtain accurate data for high-
molecular-weight PLLA and used in a standard aniso-
tropic elastic-plastic material model. The data obtained
from the material characterisation of PLLA was incorpo-
rated into the material model, with all the scaffolds having
these same material parameters. Three stent geometries
were investigated: one mimicked a typical polymer
scaffold (Absorb); a second was with a typical metal-stent
design; a third addressed the shortfalls and weaknesses of
the other two designs. C3D8RH elements were used in
simulations as they were computationally inexpensive
thanks to having only one integration point per element.
Some hourglassing issues were found for C3D8R, how-
ever, this was accounted for by enhancing hourglass con-
trol in the simulations. It was concluded that design and
geometry of scaffolds had an impact on the radial per-
formance of stents. A geometry of the typical polymer
scaffold was shown to provide the best performance in
comparison to the other two. It was concluded that all
Table 7 Scaffold simulation steps (Luo et al. 2014)
Step Detail Description
1 Crimp Rigid cylindrical tube to simulate a crimp
tool (3.5 mm ➔ 1.5 mm)
2 Elastic recoil Removal of rigid cylindrical tube
3 Expansion Rigid cylindrical body denoting balloon
catheter (➔ 3.2 mm inner radius)
4 Elastic recoil Removal of rigid cylindrical tube
Fig. 17 (a) Results of crimping and expansion simulations and (b) degradation trend at different sites across the scaffold depending on stress
(Luo et al. 2014)
Table 8 Summary of results obtained in Wang et al. (2017)
Experiment Simulation
Recoil % Crimping
Outer diameter (mm) 1.41 n/a 10.87
Expansion
Inner diameter (mm) 3.10 4.7 4.19
3.7 ~ 2 2.92
3.92 ~ 2 1.81
Radial strength (N/mm) 1.55 1.46
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stent geometries underperformed, with the polymer stent
only just presenting adequate radial strength of 322 mmHg
(magnitudes in excess of 300 mmHg are considered suffi-
cient for vessel patency (Pauck and Reddy 2015)). This ra-
dial strength value, however, was only achieved by a
significant increase of the material-stiffness to 9 GPa. With
depleting material stiffness values, the performance of all
designs diminished. Additionally, improving thickness
of scaffolds improved their performance; however, this, in
turn, could instigate damaging physiological side effects.
Additionally a study by Schiavone et al. (2016)
highlighted the importance of taking into account varia-
tions of plaque morphology within the vessel as this can
significantly impact the implantation and performance
of a scaffold. The study investigated mechanics of
stent-vessel interaction, comparing the performance of
polymeric and metallic stents with consideration of
eccentric and concentric shapes of the arterial plaque.
It was shown that polymeric scaffolds generated lower
stresses in the vessel wall, and recoiled further after
expansion than their metallic counterparts. The study
illustrated that eccentric plaque retained high stresses in
different layers of the artery. Eccentricity caused uneven
radial expansion, affecting the scaffold performance.
Simulating performance of scaffolds in vessels with
atherosclerotic lesions could enable assessment of
mechanical behaviour of different stent designs with
various plaque compositions, offering a best fit for a
patient-specific plaque.
Conclusion
Due to the increasing prevalence of bioresorbable PLLA
scaffolds, specifically stents in the medical-devices field,
there is a need to understand and quantify the mechan-
ical response of these scaffolds to in-service conditions
prior to their implant together with associated changes
in this response during their degradation. This know-
ledge will allow engineers to enhance the development
and design optimization of stents in order to improve
their performance. Issues, arising from use of metal
stents, can be relieved with the use of polymer scaffolds,
presenting many benefits compared to permanent stent-
ing, including restoration of vasomotion. Degradation
profiles of polymer scaffolds are controlled by multiple
factors including molecular weight, degree of crystallin-
ity as well as loads applied to the structure. Experimental
quantification of the non-linear mechanical response for
the viscoelastic polymer enables validation of computa-
tional (FE) models, with numerical simulations permit-
ting predictions of in-vivo behaviour of scaffolds. This
review highlighted recent progression in material models
and FE simulations endorsed by experimental testing.
Still, it is apparent that further experimental and compu-
tational studies are required to understand specific
features of mechanical behaviour of PLLA scaffolds, in-
cluding their performance prior to, and during, degrad-
ation. Additionally, developing specific material models
for each type of PLLA stent due to the different manu-
facturing procedures and compositions is necessary be-
cause of varying performance of different PLLA stents.
Achieving this will enable improvement and enhance-
ment of future generations of polymer scaffolds with im-
proved prediction of their mechanical performance,
allowing enhancement of medical procedures and accel-
erated healing of patients.
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